Table of Content

1 Neuroendocrine Tumor Drug Market Introduction and Overview
1.1 Neuroendocrine Tumor Drug Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Neuroendocrine Tumor Drug Revenue and Market Share by Manufacturer
2.2 Manufacturers Neuroendocrine Tumor Drug Area Served, Product Types
2.3 Neuroendocrine Tumor Drug Market Competitive Situation and Trends
2.3.1 Neuroendocrine Tumor Drug Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Eisai
3.1.1 Eisai Company Profile
3.1.2 Neuroendocrine Tumor Drug Product Overview
3.1.3 Eisai Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.1.4 Eisai Business Overview
3.2 Exelixis Inc.
3.2.1 Exelixis Inc. Company Profile
3.2.2 Neuroendocrine Tumor Drug Product Overview
3.2.3 Exelixis Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.2.4 Exelixis Inc. Business Overview
3.3 Foresee Pharmaceuticals LLC
3.3.1 Foresee Pharmaceuticals LLC Company Profile
3.3.2 Neuroendocrine Tumor Drug Product Overview
3.3.3 Foresee Pharmaceuticals LLC Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.3.4 Foresee Pharmaceuticals LLC Business Overview
3.4 Hutchison MediPharma Limited
3.4.1 Hutchison MediPharma Limited Company Profile
3.4.2 Neuroendocrine Tumor Drug Product Overview
3.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.4.4 Hutchison MediPharma Limited Business Overview
3.5 Intezyne Inc
3.5.1 Intezyne Inc Company Profile
3.5.2 Neuroendocrine Tumor Drug Product Overview
3.5.3 Intezyne Inc Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.5.4 Intezyne Inc Business Overview
3.6 INVENT Pharmaceuticals Inc.
3.6.1 INVENT Pharmaceuticals Inc. Company Profile
3.6.2 Neuroendocrine Tumor Drug Product Overview
3.6.3 INVENT Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.6.4 INVENT Pharmaceuticals Inc. Business Overview
3.7 Ipsen S.A.
3.7.1 Ipsen S.A. Company Profile
3.7.2 Neuroendocrine Tumor Drug Product Overview
3.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.7.4 Ipsen S.A. Business Overview
3.8 Jiangsu Hengrui Medicine Co. Ltd
3.8.1 Jiangsu Hengrui Medicine Co. Ltd Company Profile
3.8.2 Neuroendocrine Tumor Drug Product Overview
3.8.3 Jiangsu Hengrui Medicine Co. Ltd Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.8.4 Jiangsu Hengrui Medicine Co. Ltd Business Overview
3.9 Karyopharm Therapeutics Inc.
3.9.1 Karyopharm Therapeutics Inc. Company Profile
3.9.2 Neuroendocrine Tumor Drug Product Overview
3.9.3 Karyopharm Therapeutics Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.9.4 Karyopharm Therapeutics Inc. Business Overview
3.10 Lexicon Pharmaceuticals Inc.
3.10.1 Lexicon Pharmaceuticals Inc. Company Profile
3.10.2 Neuroendocrine Tumor Drug Product Overview
3.10.3 Lexicon Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.10.4 Lexicon Pharmaceuticals Inc. Business Overview
3.11 Midatech Pharma Plc .
3.11.1 Midatech Pharma Plc . Company Profile
3.11.2 Neuroendocrine Tumor Drug Product Overview
3.11.3 Midatech Pharma Plc . Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.11.4 Midatech Pharma Plc . Business Overview
3.12 Millennium Pharmaceuticals Inc.
3.12.1 Millennium Pharmaceuticals Inc. Company Profile
3.12.2 Neuroendocrine Tumor Drug Product Overview
3.12.3 Millennium Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.12.4 Millennium Pharmaceuticals Inc. Business Overview
3.13 MolMed S.p.A.
3.13.1 MolMed S.p.A. Company Profile
3.13.2 Neuroendocrine Tumor Drug Product Overview
3.13.3 MolMed S.p.A. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.13.4 MolMed S.p.A. Business Overview
3.14 Northwest Biotherapeutics Inc.
3.14.1 Northwest Biotherapeutics Inc. Company Profile
3.14.2 Neuroendocrine Tumor Drug Product Overview
3.14.3 Northwest Biotherapeutics Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
3.14.4 Northwest Biotherapeutics Inc. Business Overview
4 Global Neuroendocrine Tumor Drug Historical and Forecast Market Analysis by Type
4.1 Global Neuroendocrine Tumor Drug Revenue and Market Share by Type
4.2 Global Neuroendocrine Tumor Drug Revenue Market Forecast by Type (2024-2030)
5 Global Neuroendocrine Tumor Drug Historical and Forecast Market Analysis by Application
5.1 Global Neuroendocrine Tumor Drug Revenue Market Share by Application (2019-2024)
5.2 Neuroendocrine Tumor Drug Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Neuroendocrine Tumor Drug Market Size & Forecast (2019-2030)
6.2 Neuroendocrine Tumor Drug Growth Trends Analysis by Regions
6.2.1 Neuroendocrine Tumor Drug Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Neuroendocrine Tumor Drug Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Neuroendocrine Tumor Drug Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
7.2 North America Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
8.2 Europe Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
9.2 China Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
10.2 Japan Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
11.2 Korea Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
13.2 India Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
14.2 South America Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Neuroendocrine Tumor Drug Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa Neuroendocrine Tumor Drug Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 Neuroendocrine Tumor Drug Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Neuroendocrine Tumor Drug Industrial Chain Analysis
17 Neuroendocrine Tumor Drug Industry Dynamic Analysis
17.1 Neuroendocrine Tumor Drug Market Trends Analysis
17.2 Neuroendocrine Tumor Drug Market Drivers Analysis
17.3 Neuroendocrine Tumor Drug Market Challenges Analysis
17.4 Neuroendocrine Tumor Drug Market Restraints Analysis